Virus News and Research

Latest Virus News and Research

Antibiotic doses could be reduced by up to 50 times using new approach

Steven Hagens, previously at the University of Vienna, told Chemistry & Industry, the magazine of the SCI, that certain bacteriophages, a type of virus that infects bacteria, can boost the effectiveness of antibiotics gentamicin, gramacidin or tetracycline.

29 Jan 2007

HIV prevention and education initiatives are not reaching girls in Africa

According to Bruce, young African girls often have low school attendance and few friends, making them hard to reach. Impoverished girls are more likely to engage in commercial sex work, which increases their risk of contracting HIV, Bruce said.

28 Jan 2007

Antiretroviral resistance testing in HIV infected patients improves health and saves costs

In a newly published study Swiss researchers document that antiretroviral resistance testing in HIV infected patients with treatment failure not only leads to better health but also saves costs to society.

25 Jan 2007

FDA urged to review policy that bans MSM from donating blood

The American Red Cross and other organizations that collect donated blood are urging FDA to review a policy in effect since the early 1980s that prohibits men who have sex with men -- regardless of sexual activity, safer-sex practices or HIV status -- from donating blood, the San Jose Mercury News reports.

23 Jan 2007

Antiviral resistance and the control of pandemic influenza

Stockpiling large amounts of oseltamivir (Tamiflu) and related antiviral drugs with the intent to treat a large fraction of the population is a key part of pandemic preparedness of many countries.

23 Jan 2007

Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes

Researchers open the way for improved study of hepatitis C virus by devising a novel virus culture system that allows replication of patient-isolated virus in nontransformed hepatocytes, instead of culture-adapted virus strains in transformed cell lines.

23 Jan 2007

Ultrasensitive optical sensor detects viruses fast

Scientists of the Biophysical Engineering Group of the University of Twente in The Netherlands have developed an ultrasensitive sensor that can be used in a handheld device to, within minutes, detect various viruses and measure their concentration.

22 Jan 2007

Novavax's pandemic flu vaccines show promise

Novavax, Inc.'s novel virus-like particle (VLP) vaccines have been shown to be effective in generating protection against pandemic influenza as well as cross protection against different strains of the virus in pre-clinical studies, according to data presented at the Phacilitate Vaccine Forum.

22 Jan 2007

H5N1 genetic mutation observed in Egypt

Viruses with a genetic mutation, linked in laboratory testing to moderately reduced susceptibility to oseltamivir, have been discovered in two persons previously reported with H5N1 infections in Egypt.

22 Jan 2007

Euroscience calls for support for convicted health workers in Libya

Euroscience calls on other academic and scientific organisations to protest at the conviction of six foreign medical workers, by a Libyan court of conspiring to deliberately inject 426 Libyan children with HIV virus.

14 Jan 2007

New approach offers hope for an effective herpes vaccine

A researcher at Montana State University has called for an innovative, new approach in developing a vaccine against genital herpes.

10 Jan 2007

76th H5N1 case confirmed in Indonesia

The Ministry of Health in Indonesia has confirmed an additional two cases of human infection with the H5N1 avian influenza virus.

9 Jan 2007

Test to detect drug-resistant HIV strains could help provide earlier treatment

A test to detect drug-resistant HIV strains in people with low levels of drug-resistant viral loads could help physicians provide more effective treatment earlier to HIV-positive people, according to a study published on Sunday in the online edition of the journal Nature Methods, BBC News reports.

9 Jan 2007

Olive-pomace oil slows down spread of HIV

Olive oil has become part of the fight against the Human Immunodeficiency Virus (HIV) - the cause of AIDS - thanks to research carried out by the Bionat team, from the University of Granada, headed by Prof. Andres Garcia-Granados, senior lecturer in Organic Chemistry.

8 Jan 2007

FDA approves MedImmune's new refrigerated formulation of FluMist influenza virus vaccine

MedImmune has announced that the U.S. Food and Drug Administration (FDA) has approved the company's new refrigerated formulation of FluMist (Influenza Virus Vaccine Live, Intranasal) for use in helping to prevent influenza in healthy children and adults from 5 years to 49 years of age.

8 Jan 2007